{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T23:14:44Z","timestamp":1791846884950,"version":"4.3.4"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,18]],"date-time":"2025-08-18T00:00:00Z","timestamp":1755475200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,8,18]],"date-time":"2025-08-18T00:00:00Z","timestamp":1755475200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000026","name":"US National Institute on Drug Abuse","doi-asserted-by":"crossref","award":["R01-DA047975"],"award-info":[{"award-number":["R01-DA047975"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000026","name":"US National Institute on Drug Abuse","doi-asserted-by":"crossref","award":["R01-DA047975"],"award-info":[{"award-number":["R01-DA047975"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000026","name":"US National Institute on Drug Abuse","doi-asserted-by":"crossref","award":["R01-DA047975"],"award-info":[{"award-number":["R01-DA047975"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000026","name":"US National Institute on Drug Abuse","doi-asserted-by":"crossref","award":["R01-DA047975"],"award-info":[{"award-number":["R01-DA047975"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000026","name":"US National Institute on Drug Abuse","doi-asserted-by":"crossref","award":["R01-DA047975"],"award-info":[{"award-number":["R01-DA047975"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000026","name":"US National Institute on Drug Abuse","doi-asserted-by":"crossref","award":["R01-DA047975"],"award-info":[{"award-number":["R01-DA047975"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000026","name":"US National Institute on Drug Abuse","doi-asserted-by":"crossref","award":["R01-DA047975"],"award-info":[{"award-number":["R01-DA047975"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000026","name":"US National Institute on Drug Abuse","doi-asserted-by":"crossref","award":["R01-DA047975"],"award-info":[{"award-number":["R01-DA047975"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000026","name":"US National Institute on Drug Abuse","doi-asserted-by":"crossref","award":["R01-DA047975"],"award-info":[{"award-number":["R01-DA047975"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Harm Reduct J"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Previous research has documented differing drug use patterns and risk behaviors by gender identity and sex at birth, although variations in harm reduction practices by these characteristics have not yet been fully assessed.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>We utilized data from the Rhode Island Prescription and Illicit Drug Study (RAPIDS), which enrolled adults who used drugs from 2020 to 2023. Participants were analyzed based on gender identity: men, women, and other (including those identifying as non-binary or something else). Participants reported which harm reduction practices (e.g., use fentanyl test strips, keep naloxone nearby) they typically engaged in to avoid accidental overdose. Latent class analysis (LCA) was used to identify subgroups of harm reduction practice typologies, and a correlation matrix was generated to understand dyads of typical self-reported harm reduction practices.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Among 503 eligible participants, 64% were men, 34% were women, and 2% were non-binary or something else (<jats:italic>n<\/jats:italic>\u2009=\u20099). Harm reduction practices were comparable between men and women, although men were less likely to keep naloxone nearby (<jats:italic>p<\/jats:italic>\u2009=\u20090.02). LCA identified three subgroups of harm reduction practice typologies (no\/low, moderate, and high utilization). Group membership in latent classes did not vary by gender identity. However, those belonging to the no\/low utilization subgroup were significantly more likely to have ever been incarcerated (<jats:italic>p<\/jats:italic>\u2009=\u20090.03) and to be single (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.01). Those belonging to the high utilization group were significantly more likely to have ever witnessed an overdose, performed rescue breathing, and administered naloxone (all <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001). Correlations showed several pairwise relationships, with \u2018use fentanyl test strips\u2019 and \u2018keeping naloxone nearby\u2019 being positively and significantly correlated (<jats:italic>r<\/jats:italic>\u2009=\u20090.33, <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.05).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>We found that harm reduction practices and group membership in latent classes were largely comparable between men and women; however, men who use drugs are significantly less likely to keep naloxone nearby. Gender-attentive strategies to increase naloxone carriage and usage among men and enhanced outreach to persons characterized by no or low harm reduction practice utilization, including people who are single and those with a history of incarceration, may be warranted to mitigate overdose risk.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s12954-025-01295-9","type":"journal-article","created":{"date-parts":[[2025,8,18]],"date-time":"2025-08-18T02:51:58Z","timestamp":1755485518000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Gender-based differences in harm reduction practices among people who use drugs in Rhode Island: a latent class analysis"],"prefix":"10.1186","volume":"22","author":[{"given":"Leah C.","family":"Shaw","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anusha","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolyn J.","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine A.","family":"Lenox","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra B.","family":"Collins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan G.","family":"Sherman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brandon D. L.","family":"Marshall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandria","family":"Macmadu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,18]]},"reference":[{"key":"1295_CR1","unstructured":"Dydyk AM, Jain NK, Gupta M. Opioid Use Disorder. In: StatPearls. Treasure Island (FL): StatPearls Publishing; 2024. Available from: http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK553166\/"},{"key":"1295_CR2","doi-asserted-by":"crossref","unstructured":"Spencer MR, Garnett MF, Mini\u00f1o AM. Drug Overdose Deaths in the United States, 2002\u20132022. Washington (DC): National Center for Health Statistics; 2024. Report No.: Number 491. Available from: https:\/\/www.cdc.gov\/nchs\/products\/databriefs\/db491.htm","DOI":"10.15620\/cdc:135849"},{"issue":"11","key":"1295_CR3","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1056\/NEJMoa2401177","volume":"391","author":"The HEALing Communities Study Consortium","year":"2024","unstructured":"The HEALing Communities Study Consortium. Community-based cluster-randomized trial to reduce opioid overdose deaths. N Engl J Med. 2024;391(11):989\u20131001.","journal-title":"N Engl J Med"},{"issue":"3","key":"1295_CR4","doi-asserted-by":"publisher","first-page":"e0000769","DOI":"10.1371\/journal.pgph.0000769","volume":"3","author":"MR D\u2019Orsogna","year":"2023","unstructured":"D\u2019Orsogna MR, B\u00f6ttcher L, Chou T. Fentanyl-driven acceleration of racial, gender and geographical disparities in drug overdose deaths in the united States. PLOS Glob Public Health. 2023;3(3):e0000769.","journal-title":"PLOS Glob Public Health"},{"issue":"9","key":"1295_CR5","doi-asserted-by":"publisher","first-page":"e2232314","DOI":"10.1001\/jamanetworkopen.2022.32314","volume":"5","author":"B Han","year":"2022","unstructured":"Han B, Einstein EB, Jones CM, Cotto J, Compton WM, Volkow ND. Racial and ethnic disparities in drug overdose deaths in the US during the COVID-19 pandemic. JAMA Netw Open. 2022;5(9):e2232314.","journal-title":"JAMA Netw Open"},{"issue":"11","key":"1295_CR6","doi-asserted-by":"publisher","first-page":"1639","DOI":"10.1038\/s41386-023-01601-8","volume":"48","author":"ER Butelman","year":"2023","unstructured":"Butelman ER, Huang Y, Epstein DH, Shaham Y, Goldstein RZ, Volkow ND, et al. Overdose mortality rates for opioids and stimulant drugs are substantially higher in men than in women: state-level analysis. Neuropsychopharmacology. 2023;48(11):1639\u201347.","journal-title":"Neuropsychopharmacology"},{"key":"1295_CR7","doi-asserted-by":"publisher","first-page":"102327","DOI":"10.1016\/j.healthplace.2020.102327","volume":"63","author":"AB Collins","year":"2020","unstructured":"Collins AB, Boyd J, Czechaczek S, Hayashi K, McNeil R. (Re)shaping the self: an ethnographic study of the embodied and Spatial practices of women who use drugs. Health Place. 2020;63:102327.","journal-title":"Health Place"},{"issue":"0 1","key":"1295_CR8","doi-asserted-by":"publisher","first-page":"S176","DOI":"10.1097\/QAI.0000000000000659","volume":"69","author":"J Iversen","year":"2015","unstructured":"Iversen J, Page K, Madden A, Maher L. HIV, HCV and health-related harms among women who inject drugs: implications for prevention and treatment. J Acquir Immune Defic Syndr 1999. 2015;69(0 1):S176\u201381.","journal-title":"J Acquir Immune Defic Syndr 1999"},{"key":"1295_CR9","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.drugalcdep.2019.01.017","volume":"197","author":"JP Meyer","year":"2019","unstructured":"Meyer JP, Isaacs K, El-Shahawy O, Burlew AK, Wechsberg W. Research on women with substance use disorders: reviewing progress and developing a research and implementation roadmap. Drug Alcohol Depend. 2019;197:158\u201363.","journal-title":"Drug Alcohol Depend"},{"issue":"2","key":"1295_CR10","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1097\/COH.0000000000000042","volume":"9","author":"K Shannon","year":"2014","unstructured":"Shannon K, Goldenberg SM, Deering KN, Strathdee SA. HIV infection amongfemale sex workers in concentrated and high prevalence epidemics: Why a structural determinants framework is needed. Curr Opin HIV AIDS. 2014;9(2):174\u201382.","journal-title":"Curr Opin HIV AIDS"},{"issue":"11","key":"1295_CR11","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1016\/j.addbeh.2010.06.018","volume":"35","author":"SE Back","year":"2010","unstructured":"Back SE, Payne RL, Simpson AN, Brady KT. Gender and prescription opioids: findings from the National survey on drug use and health. Addict Behav. 2010;35(11):1001\u20137.","journal-title":"Addict Behav"},{"issue":"2","key":"1295_CR12","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.drugalcdep.2006.12.021","volume":"89","author":"V Frajzyngier","year":"2007","unstructured":"Frajzyngier V, Neaigus A, Gyarmathy VA, Miller M, Friedman SR. Gender differences in injection risk behaviors at the first injection episode. Drug Alcohol Depend. 2007;89(2):145\u201352.","journal-title":"Drug Alcohol Depend"},{"issue":"6","key":"1295_CR13","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1080\/0954012021000031877","volume":"14","author":"M Miller","year":"2002","unstructured":"Miller M, Neaigus A. Sex partner support, drug use and sex risk among HIV-negative non-injecting heroin users. AIDS Care. 2002;14(6):801\u201313.","journal-title":"AIDS Care"},{"issue":"14","key":"1295_CR14","doi-asserted-by":"publisher","first-page":"2113","DOI":"10.1081\/JA-100108439","volume":"36","author":"SG Sherman","year":"2001","unstructured":"Sherman SG, Latkin CA, Gielen AC. Social factors related to syringe sharing among injecting partners: a focus on gender. Subst Use Misuse. 2001;36(14):2113\u201336.","journal-title":"Subst Use Misuse"},{"key":"1295_CR15","unstructured":"National Institute on Drug. Sex and Gender Differences in Substance Use | National Institute on Drug Abuse (NIDA). Available from: https:\/\/nida.nih.gov\/publications\/research-reports\/substance-use-in-women\/sex-gender-differences-in-substance-use"},{"key":"1295_CR16","doi-asserted-by":"publisher","first-page":"108582","DOI":"10.1016\/j.jsat.2021.108582","volume":"132","author":"F Caravaca-S\u00e1nchez","year":"2022","unstructured":"Caravaca-S\u00e1nchez F, Aizpurua E, Wolff N. Latent class analysis of self-reported substance use during incarceration: gender differences and associations with emotional distress and aggressiveness. J Subst Abuse Treat. 2022;132:108582.","journal-title":"J Subst Abuse Treat"},{"key":"1295_CR17","doi-asserted-by":"publisher","first-page":"106142","DOI":"10.1016\/j.addbeh.2019.106142","volume":"101","author":"S Liu","year":"2020","unstructured":"Liu S, Vivolo-Kantor A. A latent class analysis of drug and substance use patterns among patients treated in emergency departments for suspected drug overdose. Addict Behav. 2020;101:106142.","journal-title":"Addict Behav"},{"issue":"1","key":"1295_CR18","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1186\/s13063-020-04898-8","volume":"21","author":"BP Jacka","year":"2020","unstructured":"Jacka BP, Goldman JE, Yedinak JL, Bernstein E, Hadland SE, Buxton JA, et al. A randomized clinical trial of a theory-based Fentanyl overdose education and Fentanyl test strip distribution intervention to reduce rates of opioid overdose: study protocol for a randomized controlled trial. Trials. 2020;21(1):976.","journal-title":"Trials"},{"issue":"32","key":"1295_CR19","doi-asserted-by":"publisher","first-page":"19151","DOI":"10.1073\/pnas.1915454117","volume":"117","author":"MAC Bind","year":"2020","unstructured":"Bind MAC, Rubin DB. When possible, report a Fisher-exact P value and display its underlying null randomization distribution. Proc Natl Acad Sci. 2020;117(32):19151\u20138.","journal-title":"Proc Natl Acad Sci"},{"key":"1295_CR20","unstructured":"Rosner B. Fundamentals of Biostatistics. seventh. Boston, MA, USA: Brooks\/Cole, Learning C. Inc.; 2015. Available from: http:\/\/repository.fue.edu.eg\/bitstream\/handle\/123456789\/2699\/5723.pdf?sequence=1&isAllowed=y"},{"key":"1295_CR21","unstructured":"Linzer D, Lewis J, poLCA. Polytomous Variable Latent Class Analysis. 2022. Available from: https:\/\/cran.r-project.org\/web\/packages\/poLCA\/index.html"},{"key":"1295_CR22","unstructured":"Wei T, Simko V. corrplot: a visual exploratory tool on correlation matrix. 2022. Available from: https:\/\/github.com\/taiyun\/corrplot"},{"key":"1295_CR23","unstructured":"R Core Team. R: A language and environment for statistical computing. R Foundation for Statistical Computing; Available from: https:\/\/www.R-project.org\/"},{"key":"1295_CR24","doi-asserted-by":"crossref","unstructured":"Terlizzi E, Zablotsky B. Symptoms of Anxiety and Depression Among Adults: United States, 2019 and 2022. Atlanta, GA: Centers for Disease Control and Prevention; 2024. (National Health Statistics Reports). Report No.: 213. Available from: https:\/\/stacks.cdc.gov\/view\/cdc\/164018","DOI":"10.15620\/cdc\/164018"},{"issue":"1","key":"1295_CR25","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1186\/s12954-023-00775-0","volume":"20","author":"T Austin","year":"2023","unstructured":"Austin T, Lavalley J, Parusel S, Collins AB, Olding M, Boyd J. Women who use drugs: engagement in practices of harm reduction care. Harm Reduct J. 2023;20(1):49.","journal-title":"Harm Reduct J"},{"issue":"1","key":"1295_CR26","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/s40352-024-00283-8","volume":"12","author":"CB Oser","year":"2024","unstructured":"Oser CB, McGladrey M, Booty M, Surratt H, Knudsen HK, Freeman PR, et al. Rapid jail-based implementation of overdose education and Naloxone distribution in response to the COVID-19 pandemic. Health Justice. 2024;12(1):27.","journal-title":"Health Justice"},{"key":"1295_CR27","doi-asserted-by":"publisher","first-page":"114293","DOI":"10.1016\/j.socscimed.2021.114293","volume":"285","author":"D Showalter","year":"2021","unstructured":"Showalter D, Wenger LD, Lambdin BH, Wheeler E, Binswanger I, Kral AH. Bridging institutional logics: implementing Naloxone distribution for people exiting jail in three California counties. Soc Sci Med. 2021;285:114293.","journal-title":"Soc Sci Med"},{"key":"1295_CR28","doi-asserted-by":"publisher","first-page":"208971","DOI":"10.1016\/j.josat.2023.208971","volume":"147","author":"DM Hartung","year":"2023","unstructured":"Hartung DM, McCracken CM, Nguyen T, Kempany K, Waddell EN. Fatal and nonfatal opioid overdose risk following release from prison: A retrospective cohort study using linked administrative data. J Subst Use Addict Treat. 2023;147:208971.","journal-title":"J Subst Use Addict Treat"},{"issue":"5","key":"1295_CR29","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1177\/0017896914550321","volume":"74","author":"TC Green","year":"2015","unstructured":"Green TC, Bowman SE, Ray M, McKenzie M, Lord SE, Rich JD. Development of an incarceration-specific overdose prevention video: staying alive on the outside. Health Educ J. 2015;74(5):627\u201337.","journal-title":"Health Educ J"},{"issue":"9","key":"1295_CR30","doi-asserted-by":"publisher","first-page":"e2125538","DOI":"10.1001\/jamanetworkopen.2021.25538","volume":"4","author":"A Macmadu","year":"2021","unstructured":"Macmadu A, Batthala S, Correia Gabel AM, Rosenberg M, Ganguly R, Yedinak JL, et al. Comparison of characteristics of deaths from drug overdose before vs during the COVID-19 pandemic in Rhode Island. JAMA Netw Open. 2021;4(9):e2125538.","journal-title":"JAMA Netw Open"},{"issue":"1","key":"1295_CR31","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1186\/s12954-024-01017-7","volume":"21","author":"W Rioux","year":"2024","unstructured":"Rioux W, Taplay P, Morris-Miller L, Ghosh SM. Implementing canada\u2019s first National virtual phone based overdose prevention service: lessons learned from creating the National overdose response service (NORS). Harm Reduct J. 2024;21(1):102.","journal-title":"Harm Reduct J"},{"issue":"1","key":"1295_CR32","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1186\/s12954-024-01053-3","volume":"21","author":"B Seo","year":"2024","unstructured":"Seo B, Rioux W, Teare A, Rider N, Jones S, Taplay P, et al. Perspectives of key interest groups regarding supervised consumption sites (SCS) and novel virtual harm reduction services \/ overdose response hotlines and applications: a qualitative Canadian study. Harm Reduct J. 2024;21(1):141.","journal-title":"Harm Reduct J"},{"issue":"2","key":"1295_CR33","doi-asserted-by":"publisher","first-page":"1230","DOI":"10.3390\/ijerph20021230","volume":"20","author":"AR Lombardi","year":"2023","unstructured":"Lombardi AR, Arya R, Rosen JG, Thompson E, Welwean R, Tardif J, et al. Overdose detection technologies to reduce solitary overdose deaths: A literature review. Int J Environ Res Public Health. 2023;20(2):1230.","journal-title":"Int J Environ Res Public Health"},{"issue":"5","key":"1295_CR34","doi-asserted-by":"publisher","first-page":"e659","DOI":"10.1016\/S2214-109X(23)00057-8","volume":"11","author":"L Degenhardt","year":"2023","unstructured":"Degenhardt L, Webb P, Colledge-Frisby S, Ireland J, Wheeler A, Ottaviano S, et al. Epidemiology of injecting drug use, prevalence of injecting-related harm, and exposure to behavioural and environmental risks among people who inject drugs: a systematic review. Lancet Glob Health. 2023;11(5):e659\u201372.","journal-title":"Lancet Glob Health"},{"issue":"1","key":"1295_CR35","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/s12954-023-00767-0","volume":"20","author":"AS Tilhou","year":"2023","unstructured":"Tilhou AS, Zaborek J, Baltes A, Salisbury-Afshar E, Malicki J, Brown R. Differences in drug use behaviors that impact overdose risk among individuals who do and do not use Fentanyl test strips for drug checking. Harm Reduct J. 2023;20(1):41.","journal-title":"Harm Reduct J"},{"issue":"1","key":"1295_CR36","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s12954-018-0276-0","volume":"16","author":"JE Goldman","year":"2019","unstructured":"Goldman JE, Waye KM, Periera KA, Krieger MS, Yedinak JL, Marshall BDL. Perspectives on rapid Fentanyl test strips as a harm reduction practice among young adults who use drugs: a qualitative study. Harm Reduct J. 2019;16(1):3.","journal-title":"Harm Reduct J"},{"key":"1295_CR37","unstructured":"State of Rhode Island General Assembly. Available from: https:\/\/www.rilegislature.gov\/pressrelease\/_layouts\/RIL.PressRelease.ListStructure\/Forms\/DisplayForm.aspx?List=c8baae31-3c10-431c-8dcd-9dbbe21ce3e9&ID=51266"},{"key":"1295_CR38","unstructured":"hampson.us RIG (RI G RI Department of Health (RIDOH). Behavioral Healthcare, Developmental Disabilities and Hospitals (BHDDH), Brown University (brown edu). Fentanyl Test Strips \u2013 Prevent Overdose RI. Available from: https:\/\/preventoverdoseri.org\/fentanyl-test-strips\/"},{"issue":"5","key":"1295_CR39","doi-asserted-by":"publisher","first-page":"e2510077","DOI":"10.1001\/jamanetworkopen.2025.10077","volume":"8","author":"RA Vickers-Smith","year":"2025","unstructured":"Vickers-Smith RA, Gelberg KH, Childerhose JE, Babineau DC, Chandler R, David JL, et al. Fentanyl test strip use and overdose risk reduction behaviors among people who use drugs. JAMA Netw Open. 2025;8(5):e2510077.","journal-title":"JAMA Netw Open"},{"key":"1295_CR40","doi-asserted-by":"publisher","first-page":"112446","DOI":"10.1016\/j.drugalcdep.2024.112446","volume":"264","author":"JE Goldman","year":"2024","unstructured":"Goldman JE, Park CJ, Trombley J, Park JN, Buxton JA, Hadland SE, et al. Prevalence and correlates of Fentanyl test strip use among people who use drugs in Rhode Island. Drug Alcohol Depend. 2024;264:112446.","journal-title":"Drug Alcohol Depend"},{"key":"1295_CR41","unstructured":"hampson.us RIG (RI G RI Department of Health (RIDOH). Behavioral Healthcare, Developmental Disabilities and Hospitals (BHDDH), Brown University (brown edu). Naloxone Data \u2013 Prevent Overdose RI. Available from: https:\/\/preventoverdoseri.org\/naloxone-data\/"},{"key":"1295_CR42","doi-asserted-by":"publisher","first-page":"104914","DOI":"10.1016\/j.drugpo.2025.104914","volume":"143","author":"CA Latkin","year":"2025","unstructured":"Latkin CA, Dayton L, Bonneau H, Davey-Rothwell MA, Gaddis A, Falade-Nwulia O. Having Naloxone when you need it: factors associated with owning and carrying Naloxone among people who use opioids. Int J Drug Policy. 2025;143:104914.","journal-title":"Int J Drug Policy"},{"issue":"6","key":"1295_CR43","doi-asserted-by":"publisher","first-page":"e251867","DOI":"10.1001\/jamahealthforum.2025.1867","volume":"6","author":"SM Rikard","year":"2025","unstructured":"Rikard SM, Doshi K, Guy GP Jr, Schmit KM. Awareness of and beliefs about Naloxone among adults. JAMA Health Forum. 2025;6(6):e251867.","journal-title":"JAMA Health Forum"},{"key":"1295_CR44","unstructured":"NaloxBoxes. put lifesaving overdose drugs within ready reach | Brown University. Available from: https:\/\/www.brown.edu\/news\/2017-07-12\/naloxbox"},{"key":"1295_CR45","first-page":"112384","volume":"234","author":"AB Collins","year":"2019","unstructured":"Collins AB, Boyd J, Cooper HLF, McNeil R. The intersectional risk environment of people who use drugs. Soc Sci Med 1982. 2019;234:112384.","journal-title":"Soc Sci Med 1982"},{"key":"1295_CR46","unstructured":"Prevent Overdose Rhode Island. Learn More About Fentanyl \u2013 Prevent Overdose RI. Available from: https:\/\/preventoverdoseri.org\/fentanyl\/"}],"container-title":["Harm Reduction Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12954-025-01295-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12954-025-01295-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12954-025-01295-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T17:03:56Z","timestamp":1758992636000},"score":1,"resource":{"primary":{"URL":"https:\/\/harmreductionjournal.biomedcentral.com\/articles\/10.1186\/s12954-025-01295-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,18]]},"references-count":46,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1295"],"URL":"https:\/\/doi.org\/10.1186\/s12954-025-01295-9","relation":{},"ISSN":["1477-7517"],"issn-type":[{"value":"1477-7517","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,18]]},"assertion":[{"value":"26 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The RAPIDS study was approved by the Brown University Institutional Review Board. All participants provided informed consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"140"}}